We would love to hear your thoughts about our site and services, please take our survey here.
Worth a read
https://www.linkedin.com/posts/paul-hill-a5994116_bell-bell-activity-7112321492083687424-5aXY/?utm_source=share&utm_medium=member_desktop
IMHO
Excellent news from Bell to say the least.
Belluscura plc
("Belluscura" or the "Company")
Belluscura Receives Approval and First Purchase Order in Hong Kong and commences the manufacture of the first DISCOV-R(TM) units
Belluscura secures its first approval in phase one of its exclusive license agreement with Innomax Licensing Agreement
LONDON, U.K. and PLANO, TX, U.S. (26 September 2023). Belluscura plc (AIM:BELL), a leading medical device developer focused on lightweight and portable oxygen enrichment technology, announces that it has received approval from the Hong Kong Department of Health - Medical Device Division to distribute the X-PLOR(R) portable oxygen concentrator.
Belluscura has already received its first purchase order from a Hong Kong distributor. Hong Kong is part of the licensed territory in its Exclusive License Agreement signed last month with Innomax Medical Device Technologies.
The Company is also pleased to announce the successful completion of the DISCOV-R(TM) portable oxygen concentrator patient usability study with all participants providing favorable feedback on the device. Initial production of the DISCOV-R(TM) will commence this week. Full-scale production is being planned in conjunction with Innomax in response to the significant preliminary demand already received by the Company.
The short really is a case of roles reversed we all know that these have to come on to the market at some point. The pressure is building massively. The get out for the shorts are slowly disappearing especially if they raise funding without an equity raise. Key players were in the US obviously finance talks are ongoing it might be closer than we think imho
One of the most encouraging underlying themes of the webinar was the commentary around funding, avoiding dilution and ongoing discussions with all sorts of funding options.
If they can fund the $120m without equity which was hinted at that would have incredible positive implications for the share price.
I stick by my comments short is in real trouble
IMHO
Shorts in big trouble Pantheon shareholders have an opportunity to really pile the pressure on the short by all buying a few shares. At the end of the day current market cap is low given the contingent resource. Webinar should massively highlight this. Any sensible farm in and this will fly. Imho
At current levels of market cap the risk and reward is very much there for a major. with the close proximity to the pipeline the capex requirement is barely the infrastructure costs elsewhere on the North Slope. we are talking huge numbers on a success case basis IMHO
At current price I do like the short in place, as a holder I have a strong view we are currently massively undervalued the power of the short closing at some point is going to be very interesting. I still feel there is a strong probability of a farm out and or bid which will really put the short under big pressure IMHO
The cracks are appearing when you say they wouldn't increase the short unless they were 100% sure.
I bet they were 100% sure of the bond shares coming on to the market this month.
I am 100% sure they aren't.
IMHO